Clinical evaluation of schizophyllan adjuvant immunochemotherapy for patients with resectable gastric cancer —A randomized controlled trial—
- 1 July 1984
- journal article
- research article
- Published by Springer Nature in Surgery Today
- Vol. 14 (4) , 286-292
- https://doi.org/10.1007/bf02469643
Abstract
Adjuvant immunochemotherapy using schizophyllan (SPG), an extract from the culture broth ofSchizophyllum commune Fries, was prescribed at random for 326 Japanese patients with resectable gastric cancer. The overall survival rates for 3 years did not differ between the SPG and control groups. In 62 patients with stage I gastric cancer and 67 with stage II, there was little difference in the 3-year survival rates. The survival rates for 100 patients with stage III were enhanced at p=0.0811 in the SPG group, as compared to the controls. The survival rates in 97 patients with stage IV cancer were much the same. These results warrant further application of this immunopotentiating drug for treating patients with resectable gastric cancer.Keywords
This publication has 11 references indexed in Scilit:
- [Multihospital randomized study on the adjuvant chemotherapy with mitomycin-C and Futraful for gastric cancer V. Estimation of 5-year survival rate].1982
- [Immunological studies on patients with gastrointestinal cancer - with particular emphasis on influence of surgery and immunomodulators (author's transl)].1981
- The general rules for the gastric cancer study in surgery and pathologySurgery Today, 1981
- Inhibition of pulmonary metastasis of Lewis lung carcinoma by a glucan, Schizophyllan.1981
- Clinical value of immunochemotherapy with OK-432 or PS-K for stomach cancer patientsSurgery Today, 1979
- Post-operative long-term adjuvant immunochemotherapy with mitomycin-C, PSK and FT-207 in gastric cancer patientsSurgery Today, 1979
- Protracted Oral Chemotherapy with Fluorinated Pyrimidines as an Adjuvant to Surgical Treatment for Stomach CancerAnnals of Surgery, 1977
- Gastric Cancer: Current Status of TreatmentJNCI Journal of the National Cancer Institute, 1977
- Host-mediated antitumor action of schizophyllan, a glucan produced by Schizophyllum commune.1969
- LARGE-DOSE ADMINISTRATION OF MITOMYCIN-C DURING GASTRECTOMY FOLLOWED BY HOMOLOGOUS BONE MARROW TRANSPLANTATION1964